OTCQX: BLEVF CNSX: BE CORPORATE PRESENTATION JANUARY 2019
Our Vision: Beleave will continue to be a leading, global, vertically-integrated cannabis company. We cultivate high-quality cannabis flower and extracts, and are developing additional product lines for 2019. With a footprint in Canada, South America, and Europe, we are well on our way. January 2019 OTCQX: BLEVF 2 Beleave Inc. CNSX: BE www.beleave.com
Who We Are Product Development Production Sales and Retail Built on Research Capacity Distribution Expansion Current provincial supply R&D Team focused on Anticipated production Retail channel providing agreements with access to developing products to facility footprint in excess province-wide access to over 55% of the capitalize on concentrates and of 500,000 sq ft Saskatchewan market Canadian population edibles when allowed in 2019 Industry leading yields Pre-qualified for retail Strategy to capitalize on Proprietary extraction locations in Manitoba international opportunities and processing techniques Facilities will be with agreements in supply (patent pending) strategically located across Flagship store to be South American and Canada and abroad built at production European markets Collaboration with facility in Ontario academic institutions Diversified brands in, development, able to serve large and niche markets alike January 2019 OTCQX: BLEVF 3 Beleave Inc. CNSX: BE www.beleave.com
2018 and Beyond Fall/Winter 2019 London, Ontario Facility comes online with September 20 nearly 250,000 square Beleave Announces July 19 feet of indoor and Planned Indoor Beleave Accelerates greenhouse space Growing Capacity in its Recreational British Columbia Distribution Strategy Fall 2019 by Acquiring Recreational market Seven Oaks expands as commercially November 15 manufactured edibles, Beleave Announces beverages, and concentrates August 21 Development of are legalized Beleave Starts Cannabis-Infused Receiving POs Powder and Sugar from Ontario, BC, Products for the May 10 and Manitoba Recreational Market October 17 Beleave Closes Recreational Acquisition of Cannabis is Medi-Green August 30 Legalized in Canada Cannabis Clinic Beleave Secures Network Prime Location for its First Summer 2020 Saskatchewan The two BC facilities Retail Store are completed, adding 173,000 square feet to growing capacity Spring 2019 Hamilton, Ontario October 29 Facility Receives Beleave Expands September 6 GMP/ISO Certification into European Beleave Signs Cannabis Market April 13 Agreement to Acquire June 21 Beleave Receives Nearly 250,000 Square Beleave Expands Sales License from Feet of Greenhouse its Global Health Canada Space and 85 Acres of Footprint into Colombia Land to Expand its Production Capabilities January 2019 OTCQX: BLEVF 4 Beleave Inc. CNSX: BE www.beleave.com
In the News November 9, 2018 “Follow the Money Investors Group interviews Bojan Krasic, President & CFO of Beleave Inc. October 17, 2018 Beleave invites CP24 cameras into their Hamilton facility for a tour and learn more about their operations the morning of Canadian cannabis legalization. September 12, 2018 “Touting London's proximity to highways and its large labour pool, a pot producer has bought up a greenhouse on a sprawling property in the city's south end.” August 31, 2018 “Are you experienced? Lloydminster marijuana retailer looking for 'qualified' workers.” August 29, 2018 “B.C. government has begun to buy bud.” Beleave in the News August 23, 2018 Whether it’s a story on “Growth on the horizon for licensed pot producers.” cannabis employers and entrepreneurs, or a live June 30, 2017 interview the morning “With a year to go and amid predictions of a looming recreational cannabis supply shortage, Health Canada is scrambling to add became legal in Canada, capacity once the legalization floodgates swing open.” Beleave has had great May 10, 2017 newsworthy moments. “Marijuana startups get new funding from 'streaming' deals.” March 25, 2017 “Hamilton is home to at least three major marijuana cultivators, among the 40 growers licensed by the federal government to grow pot for medicinal purposes.” January 2019 OTCQX: BLEVF 5 Beleave Inc. CNSX: BE www.beleave.com
Facilities: Expansion Phases Hamilton, Ontario London, Ontario British Columbia The first property in the Beleave 250, 000 sq ft existing greenhouse Ten indoor growing facilities jointly- portfolio, the Hamilton facility to be retrofitted on an 85 designed by Beleave and Kannavis continues to be the hub of operations acre property. Biotech Corp., on a 50/50 operating expenditure and revenue partnership. for extraction, packaging, and distribution. Phase 1 Phase 1 Starting Fall 2019 GMP Certification: Indoor: 26,700 sq ft Starting Summer 2020 Expected in Spring 2019 Indoor: Abbotsford 86,700 sq ft Indoor: Chilliwack 86,700 sq ft Phase 2 ISO Certification: Starting Fall 2019 Anticipated in early 2019 Greenhouse: 36,700 sq ft Certification will facilitate Phase 3 international distribution Starting Early 2020 Greenhouse: 174,950 sq ft Expansion: Indoor: 5,700 sq ft Starting Fall 2019 Greenhouse: 80,000 sq ft Indoor: 6,000 sq ft January 2019 OTCQX: BLEVF 6 Beleave Inc. CNSX: BE www.beleave.com
Sales and Distribution: Today Beleave has access to over half of the Canadian recreational Canada marketplace; that number is expected to soar to over 97% in 2020. Medical Distribution Recreational Distribution Now Now Fall 2019 Countrywide BC, MB, ON + AB, SK 69.8 % of Canada 100 % of Canada 55.1 % of Canada Early 2020 Mid 2020 + QB, NS, NB + YT, NT, NU, NL 97.5 % of Canada 99.59 % of Canada Planned Retail Location Planned Recreational Online Sales Provincial population percentages based on 2016 Canadian Census January 2019 OTCQX: BLEVF 7 Beleave Inc. CNSX: BE www.beleave.com
Sales and Distribution: South America • Andcipated distribudon throughout Colombia and other South American markets • Low cost of facility construcdon and operadons keep expenses low South American Expansion In June 2018, Beleave expanded • As reguladons for medical cannabis its global footprint into South America by acquiring a majority change in the region, the market of share in Procannmed; fully licensed for the cultivation, 620 million people will present new production, extraction and growth opportunides for Beleave distribution of both THC and CBD medical cannabis in Colombia. January 2019 OTCQX: BLEVF 8 Beleave Inc. CNSX: BE www.beleave.com
Sales and Distribution: Europe • Canymed has agreed to import up to 5,000 kg of dry flower per year from Beleave at a target price of €7.00/g if licensed • Beleave will receive 10% ownership in Canymed and first right of refusal for European Expansion an addidonal 20% in exchange for In October 2018, Beleave expanded its global footprint providing experdse, training, again * , this time to Europe, by partnering with Canymed who consultadon and support has applied to supply the German market with medical cannabis. • Germany has quickly become one of the world's largest federally-regulated medical cannabis market *Pending government approvals and GMP Certification January 2019 OTCQX: BLEVF 9 Beleave Inc. CNSX: BE www.beleave.com
Market Overview Medical Market Recreational Market Growing Market Industry Growth Conservative estimates from Health Recreational market in Canada is expected Canada predict that the size of the require cannabis production of over medical cannabis market will reach 900,000 kg annually to meet its estimated 450,000 patients in the next six years. value of $8.7 billion in the next six years. Export Opportunities Retail Distribution New opportunities are on the horizon Many provinces will soon be, or already are, for Canadian LPs to supply foreign in the process of accepting applications for medical markets as many South more point-of-sale locations, and retail American and European nations lack distribution points are expected to grow domestic production capacity. substantially in 2019. New Product Lines Impactful Research Companies are committing R&D resources Impactful studies highlight the promise 2019 to develop a wide variety of new product of cannabis to aid in healthy aging, offerings as the recreational market will allow neurological and degenerative diseases, for edibles, concentrates, and beverage- and as a powerful weapon against the based cannabis products in 2019. opioid crisis. January 2019 OTCQX: BLEVF 10 Beleave Inc. CNSX: BE www.beleave.com
Recommend
More recommend
